These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2647819)

  • 21. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
    Wallin A; Sandström T; Rosenhall L; Melander B
    Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group.
    Welch M; Bernstein D; Gross G; Kane RE; Banerji D
    Chest; 1999 Nov; 116(5):1304-12. PubMed ID: 10559092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
    Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
    Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind comparison of acute effects of inhaled albuterol, isoproterenol and placebo on cardiopulmonary function and gas exchange in asthmatic children.
    Littner MR; Tashkin DP; Siegel SC; Katz R
    Ann Allergy; 1983 May; 50(5):309-16. PubMed ID: 6846920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
    N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metered dose inhaler with spacer versus dry powder inhaler for delivery of salbutamol in acute exacerbations of asthma: a randomized controlled trial.
    Lodha R; Gupta G; Baruah BP; Nagpal R; Kabra SK
    Indian Pediatr; 2004 Jan; 41(1):15-20. PubMed ID: 14767083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled albuterol powder for the treatment of asthma--a dose-response study.
    Orgel HA; Meltzer EO; Welch MJ; Kemp JP
    J Allergy Clin Immunol; 1985 Apr; 75(4):468-71. PubMed ID: 3884688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical equivalence of a novel multiple dose powder inhaler versus a conventional metered dose inhaler on bronchodilating effects of salbutamol.
    Vidgren M; Silvasti M; Korhonen P; Kinkelin A; Frischer B; Stern K
    Arzneimittelforschung; 1995 Jan; 45(1):44-7. PubMed ID: 7893268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
    Berger WE; Milgrom H; Chervinsky P; Noonan M; Weinstein SF; Lutsky BN; Staudinger H
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of salbutamol dry powder aerosol with pressurised aerosol.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 1993; 35(4):163-6. PubMed ID: 8039816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
    Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
    Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
    Orgel HA; Kemp JP; Tinkelman DG; Webb DR
    J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices.
    Bronsky EA; Pearlman DS; Pobiner BF; Scott C; Wang Y; Stahl E
    Pediatrics; 1999 Sep; 104(3 Pt 1):501-6. PubMed ID: 10469776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of albuterol 1.25 mg and 0.62 mg for nebulization in 6- to 12-year-old children with moderately severe asthma.
    Kemp J; Turck CJ; York JM
    Adv Ther; 2007; 24(3):463-77. PubMed ID: 17660154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.